Income Statement (TTM)
Sun Pharma Advanced Research Company Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,454 | 2,476 | 2,530 | 895 | 997 | 1,401 | 1,372 | 1,437 | 1,474 | 2,163 | 2,388 | 2,343 | 2,239 | 1,067 | 755 | 684 | 601 | 611 | 718 | 646 |
| Change (%) | 0.90 | 2.16 | -64.62 | 11.43 | 40.45 | -2.01 | 4.71 | 2.55 | 46.77 | 10.38 | -1.89 | -4.42 | -52.36 | -29.19 | -9.45 | -12.16 | 1.75 | 17.39 | -9.99 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 87 | 99 | 329 | 174 | 247 | 223 | 236 | 245 | 300 | 314 | 283 | 278 | 287 | 327 | 364 | 358 | 376 | 332 | 302 | 308 |
| Change (%) | 14.25 | 230.56 | -47.02 | 41.75 | -9.68 | 5.70 | 4.12 | 22.50 | 4.59 | -9.88 | -1.87 | 3.20 | 13.88 | 11.56 | -1.76 | 5.14 | -11.82 | -9.01 | 1.99 | |
| % of Revenue | 3.55 | 4.01 | 12.99 | 19.45 | 24.75 | 15.91 | 17.17 | 17.07 | 20.39 | 14.53 | 11.86 | 11.86 | 12.81 | 30.62 | 48.23 | 52.33 | 62.64 | 54.29 | 42.08 | 47.68 |
| Gross Operating Profit | 2,367 | 2,377 | 2,201 | 721 | 750 | 1,178 | 1,137 | 1,192 | 1,173 | 1,849 | 2,105 | 2,065 | 1,952 | 740 | 391 | 326 | 224 | 279 | 416 | 338 |
| Change (%) | 0.41 | -7.39 | -67.25 | 4.10 | 56.94 | -3.47 | 4.84 | -1.55 | 57.58 | 13.82 | -1.89 | -5.45 | -62.09 | -47.16 | -16.62 | -31.16 | 24.50 | 48.73 | -18.69 | |
| % of Revenue | 96.45 | 95.99 | 87.01 | 80.55 | 75.25 | 84.09 | 82.83 | 82.93 | 79.61 | 85.47 | 88.14 | 88.14 | 87.19 | 69.38 | 51.77 | 47.67 | 37.36 | 45.71 | 57.92 | 52.32 |
| SG&A | 1,454 | 1,452 | 1,457 | 1,412 | 1,513 | 1,526 | 1,658 | 1,803 | 1,844 | 2,157 | 2,390 | 2,544 | 2,783 | 2,787 | 2,944 | 2,982 | 2,948 | 2,719 | 2,454 | 2,105 |
| Change (%) | -0.13 | 0.32 | -3.04 | 7.13 | 0.85 | 8.68 | 8.70 | 2.29 | 16.97 | 10.83 | 6.41 | 9.42 | 0.14 | 5.62 | 1.29 | -1.13 | -7.78 | -9.75 | -14.21 | |
| % of Revenue | 59.24 | 58.64 | 57.58 | 157.80 | 151.72 | 108.94 | 120.83 | 125.43 | 125.10 | 99.70 | 100.11 | 108.58 | 124.31 | 261.28 | 389.70 | 435.91 | 490.68 | 444.75 | 341.94 | 325.92 |
| R&D | 2,129 | 2,220 | 1,840 | 1,500 | 1,219 | 1,129 | 1,084 | 1,170 | 1,187 | 1,247 | 1,495 | 1,534 | 1,443 | 1,372 | 1,014 | 829 | 902 | 923 | 813 | 683 |
| Change (%) | 4.27 | -17.12 | -18.46 | -18.76 | -7.38 | -3.97 | 7.92 | 1.43 | 5.04 | 19.90 | 2.62 | -5.93 | -4.92 | -26.12 | -18.19 | 8.83 | 2.29 | -11.88 | -15.98 | |
| % of Revenue | 86.77 | 89.67 | 72.75 | 167.64 | 122.23 | 80.61 | 79.00 | 81.42 | 80.53 | 57.63 | 62.60 | 65.47 | 64.44 | 128.60 | 134.16 | 121.20 | 150.17 | 150.98 | 113.33 | 105.79 |
| OpEx | 4,251 | 4,370 | 3,987 | 3,502 | 3,323 | 3,208 | 3,333 | 3,647 | 3,760 | 4,179 | 4,624 | 4,823 | 5,010 | 5,027 | 4,873 | 4,713 | 4,744 | 4,465 | 4,055 | 3,566 |
| Change (%) | 2.82 | -8.78 | -12.16 | -5.11 | -3.47 | 3.92 | 9.42 | 3.08 | 11.15 | 10.66 | 4.30 | 3.88 | 0.35 | -3.08 | -3.27 | 0.66 | -5.88 | -9.18 | -12.06 | |
| % of Revenue | 173.21 | 176.50 | 157.60 | 391.28 | 333.20 | 229.00 | 242.86 | 253.78 | 255.07 | 193.16 | 193.66 | 205.87 | 223.74 | 471.24 | 644.98 | 689.03 | 789.60 | 730.40 | 565.06 | 552.07 |
| Operating Income | -1,797 | -1,894 | -1,457 | -2,607 | -2,326 | -1,807 | -1,961 | -2,210 | -2,286 | -2,015 | -2,236 | -2,480 | -2,771 | -3,960 | -4,117 | -4,029 | -4,143 | -3,854 | -3,338 | -2,920 |
| Change (%) | 5.43 | -23.08 | 78.93 | -10.79 | -22.30 | 8.51 | 12.72 | 3.42 | -11.83 | 10.97 | 10.90 | 11.71 | 42.93 | 3.96 | -2.13 | 2.83 | -6.99 | -13.40 | -12.51 | |
| % of Revenue | -73.21 | -76.50 | -57.60 | -291.28 | -233.20 | -129.00 | -142.86 | -153.78 | -155.07 | -93.16 | -93.66 | -105.87 | -123.74 | -371.24 | -544.98 | -589.03 | -689.60 | -630.40 | -465.06 | -452.07 |
| Interest Expense | -50 | -82 | -107 | -140 | -163 | -151 | -133 | -96 | -90 | -96 | -76 | -63 | -37 | -10 | -12 | -15 | -24 | -49 | -85 | -141 |
| Change (%) | 65.26 | 29.80 | 31.92 | 16.02 | -7.18 | -11.91 | -28.05 | -5.75 | 6.64 | -20.79 | -17.94 | -41.50 | -72.86 | 18.10 | 25.54 | 59.67 | 107.87 | 72.78 | 66.57 | |
| % of Revenue | -2.02 | -3.31 | -4.21 | -15.70 | -16.34 | -10.80 | -9.71 | -6.67 | -6.13 | -4.46 | -3.20 | -2.67 | -1.64 | -0.93 | -1.55 | -2.16 | -3.92 | -8.01 | -11.78 | -21.81 |
| Net Income | -1,819 | -1,940 | -1,511 | -2,692 | -2,408 | -1,891 | -2,034 | -2,244 | -2,376 | -2,116 | -2,226 | -2,356 | -2,536 | -3,634 | -3,872 | -3,878 | -4,087 | -3,885 | -3,425 | -2,985 |
| Change (%) | 6.66 | -22.08 | 78.11 | -10.53 | -21.50 | 7.58 | 10.32 | 5.91 | -10.94 | 5.17 | 5.84 | 7.65 | 43.30 | 6.55 | 0.14 | 5.39 | -4.93 | -11.85 | -12.86 | |
| % of Revenue | -74.11 | -78.34 | -59.75 | -300.78 | -241.51 | -134.98 | -148.19 | -156.12 | -161.23 | -97.83 | -93.22 | -100.56 | -113.26 | -340.66 | -512.56 | -566.86 | -680.16 | -635.53 | -477.26 | -462.07 |
Source: Capital IQ
